Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 10/14/11 → 06/10/16 |
Funding
- Amgen Incorporated: $100,371.25
A Phase I Study Evaluating the Safety,Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered AMG 900 in Adult Subjects with Acute Leukemias and Related Disorders
- Schuster, Michael (PI)
- Gabig, Theodore (CoPI)
- Lan, Fengshuo (CoPI)
- Kiner-Strachan, Bonnie (CoPI)
- Richard, Shambavi (CoPI)
Project: Research